If a Bear Market Is Coming, This Is the Single Best Investing Decision You Can Make

The article warns that if the S&P 500 falls 20%+ from recent highs, a bear market could loom, and it argues investors should avoid panic-selling. It cites research that 48% of the S&P 500’s best days (1996-2025) occurred during bear markets and that missing the 10/20/30 best days after a 1996 $10,000 investment cuts ending value from $192,167 to $85,490/$49,551/$31,123. It also notes bear markets have averaged under 10 months with average stock drawdowns around 35%, and suggests diversification (e.g., consumer goods, Dividend Kings) to reduce the urge to sell at the bottom.

Analysis

This is less a fundamental event than a positioning signal: in a drawdown, the highest-conviction move is usually to avoid forced selling, because the rebound days are disproportionately clustered near stress peaks. That matters most for high-beta growth and crowded factor exposures, where liquidity becomes the risk premium and the first leg down is often driven by systematic de-grossing rather than earnings revisions.

Relative winners in a tape like this are the names with low refinancing risk, stable free cash flow, and the ability to act as “portfolio ballast” during volatility spikes. That favors defensive cash generators and durable compounders over long-duration assets; within the cited universe, NVDA is better insulated than most cyclical tech because pullbacks often attract incremental allocation from underexposed funds, while lower-quality small/micro caps face the sharpest multiple compression as bid-ask spreads widen.

The contrarian point the article misses is that “stay invested” is not the same as “stay fully exposed.” For institutions, the edge is in pre-committing to rebalance rules, adding on forced-liquidation days, and using volatility to rotate from crowded beta into quality. The thesis breaks if macro data or funding stress turns this from a garden-variety correction into a balance-sheet event; in that case, liquidity-sensitive names can underperform for months, not days.

Key Decisions for Investors

• Overweight NVDA vs the broad market on a 1-3 month horizon; use any 3-5% market-wide selloff to add. Falsifier: if NVDA loses leadership and underperforms QQQ by >10% over the next earnings cycle, the relative-quality bid is failing.
• Run a defensive barbell: long XLP or NOBL, short IWM or a high-beta small-cap basket, for the next 4-8 weeks. This captures the usual widening in quality vs junk during de-risking without needing an outright market call.
• If already long growth, buy limited-drawdown protection on QQQ or SMH rather than panic-selling; target 2-3 month put spreads into the next macro release window. Exit the hedge if vol compresses and breadth improves for two consecutive weeks.
• Treat GETY and similar liquidity-sensitive small caps as avoid/underweight until market breadth stabilizes. The risk/reward is poor in risk-off because funding and multiple compression can outrun any single-name catalyst.
• Use a staged-buy list for NFLX and other subscription compounders on sharp down days, but only if there is no simultaneous deterioration in ad-spend, churn, or consumer confidence. Falsifier: any guide-down tied to weaker consumer demand would negate the defensive thesis.